Cargando…
Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021
BACKGROUND: Tokyo, the capital of Japan, is a densely populated city of >13 million people, so the population is at high risk of epidemic severe acute respiratory coronavirus 2 (SARS-CoV-2) infection. A serologic survey of anti–SARS-CoV-2 IgG would provide valuable data for assessing the city’s S...
Autores principales: | Sanada, Takahiro, Honda, Tomoko, Yasui, Fumihiko, Yamaji, Kenzaburo, Munakata, Tsubasa, Yamamoto, Naoki, Kurano, Makoto, Matsumoto, Yusuke, Kohno, Risa, Toyama, Sakiko, Kishi, Yoshiro, Horibe, Takuro, Kaneko, Yudai, Kakegawa, Mayumi, Fukui, Kazushige, Kawamura, Takeshi, Daming, Wang, Qian, Chungen, Xia, Fuzhen, He, Fan, Yamasaki, Syudo, Nishida, Atsushi, Harada, Takayuki, Higa, Masahiko, Tokunaga, Yuko, Takagi, Asako, Itokawa, Masanari, Kodama, Tatsuhiko, Kohara, Michinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Epidemiological Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761565/ https://www.ncbi.nlm.nih.gov/pubmed/34776499 http://dx.doi.org/10.2188/jea.JE20210324 |
Ejemplares similares
-
Response to the Letter to the Editor Regarding “Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021”
por: Sanada, Takahiro, et al.
Publicado: (2023) -
Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice
por: Yasui, Fumihiko, et al.
Publicado: (2022) -
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2021) -
Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023) -
Analysis of the mechanism by which BALB/c mice having prior immunization with nucleocapsid protein of SARS-CoV develop severe pneumonia after SARS-CoV infection
por: Yasui, Fumihiko, et al.
Publicado: (2010)